A detailed history of Farallon Capital Management LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 11,317,692 shares of RVMD stock, worth $502 Million. This represents 2.58% of its overall portfolio holdings.

Number of Shares
11,317,692
Previous 9,757,692 15.99%
Holding current value
$502 Million
Previous $379 Million 35.41%
% of portfolio
2.58%
Previous 1.83%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$36.92 - $47.94 $57.6 Million - $74.8 Million
1,560,000 Added 15.99%
11,317,692 $513 Million
Q2 2024

Aug 14, 2024

BUY
$30.14 - $40.68 $67.8 Million - $91.5 Million
2,249,820 Added 29.97%
9,757,692 $379 Million
Q1 2024

May 15, 2024

BUY
$26.56 - $33.55 $20.5 Million - $25.9 Million
771,018 Added 11.44%
7,507,872 $242 Million
Q4 2023

Feb 14, 2024

BUY
$18.35 - $34.12 $124 Million - $230 Million
6,736,854 New
6,736,854 $193 Million
Q3 2023

Nov 14, 2023

BUY
$25.17 - $35.05 $83.7 Million - $117 Million
3,325,480 New
3,325,480 $92 Million
Q2 2023

Aug 14, 2023

SELL
$20.28 - $27.0 $10.1 Million - $13.5 Million
-500,120 Reduced 15.23%
2,783,480 $74.5 Million
Q1 2023

May 15, 2023

BUY
$20.76 - $30.09 $32.9 Million - $47.7 Million
1,585,585 Added 93.38%
3,283,600 $71.1 Million
Q4 2022

Feb 14, 2023

SELL
$17.68 - $25.53 $14.2 Million - $20.5 Million
-801,985 Reduced 32.08%
1,698,015 $40.4 Million
Q3 2022

Nov 14, 2022

SELL
$17.46 - $26.0 $13.1 Million - $19.5 Million
-750,000 Reduced 23.08%
2,500,000 $49.3 Million
Q1 2022

May 16, 2022

BUY
$17.31 - $26.4 $8.66 Million - $13.2 Million
500,000 Added 18.18%
3,250,000 $82.9 Million
Q3 2021

Nov 15, 2021

BUY
$23.95 - $33.41 $5.99 Million - $8.35 Million
250,000 Added 10.0%
2,750,000 $75.7 Million
Q2 2021

Aug 13, 2021

BUY
$29.0 - $47.44 $25.8 Million - $42.2 Million
890,270 Added 55.31%
2,500,000 $79.4 Million
Q1 2021

May 17, 2021

BUY
$37.21 - $54.43 $59.1 Million - $86.5 Million
1,588,997 Added 7664.1%
1,609,730 $73.9 Million
Q1 2020

May 15, 2020

BUY
$20.0 - $34.08 $414,660 - $706,580
20,733 New
20,733 $454,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.89B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.